Trans-Pacific Partnership Agreement

The Trans-Pacific Partnership Agreement (TPP)  is a massive free trade agreement involving Australia and ten other Pacific Rim countries, which reduces our democratic rights while increasing the rights of global corporations. The TPP is bad for:

  • Democracy. It allows global corporations to sue governments over health, environment and public interest laws. Read more.
  • Workers. Contains no real protection for labour rights or migrant workers, and removes labour market testing for temporary migrant workers. Read more.
  • Essential services:  locks in deregulation, promotes privatisation and prevents future governments from regulating in the public interest, Read more
  • The environment. Lacks enforceable commitments to key international agreements, does not mention climate change and allows corporations to sue over new environmental laws. Read more.
  • Internet users. Locks in strong rights for copyright holders at the expense of consumers and internet users. Read more.

After six years of community campaigning, the withdrawal of the US in January 2017 meant the original TPP-12 could not proceed, but the 11 remaining governments suspended some clauses and rebadged it as the Comprenensive Progressive TPP or  TPP-11, which was signed in March 2018 and approved for ratification by the Australian Parliament in October 2018,   If six of the eleven countries ratify it before the end of 2018, it will come into force for those countries in 2019.

For in-depth analysis and resources, including AFTINET’s submissions to parliamentary inquiries, click here. 

Updated October  2018

No TPP campaign continues

November 28, 2017: The Turnbull government is trying to revive the TPP and retain many of the worst US-initiated clauses. The TPP-11 leaders have not met their deadline to finalise the text, but at the latest round of negotiations they salvaged a possible deal. The agreement has been rebranded the ' Comprehensive and Progressive TPP', and some of its most controversial clauses have been suspended, pending the US rejoining the agreement. The negotiations will continue in 2018.

TPP 11 need for further talks show flaws in the deal

Media Release November 11, 2017: “TPP 11 leaders meeting in Da Nang Vietnam have  agreed on some elements of a possible deal without the US, but have not succeeded in their aim of finalising the text. The talks have only been salvaged by an agreement to rename the deal, suspend some of its most controversial clauses and to have further talks over several months on issues raised by Canada and other governments,” AFTINET Convener Dr Patricia Ranald said today.

New study shows TPP could cost PBS hundreds of millions

November 9, 2017: new paper by leading health experts published in the Australian Health Review and summarised in Fairfax news and The Conversation has found that the Trans-Pacific Partnership agreement could add up to $367 million to the cost of the Pharmaceutical Benefits Scheme if increases in data protection monopolies for biologic medicines proposed in the original TPP text are implemented.

Pages